A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Cervical Dystonia and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (POSTURe)

This is an observational study to assess health-related quality of life in patients with cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice.

Inclusion Criteria:

• Diagnosis of cervical dystonia (dystonie) and able to receive botulinum toxin Type A as deemed medically necessary by the physician

Exclusion Criteria:

• Participation in a clinical trial for any botulinum toxin indication
• Planning elective surgery during the observational study period
• Treatment with any botulinum toxin product for cervical dystonia (dystonie)
• Treatment with any botulinum toxin product for a non-cervical dystonia (dystonie) condition within 2 months of study start